Viking Therapeutics Inc (VKTX)
49.58
-3.99
(-7.45%)
USD |
NASDAQ |
Nov 15, 16:00
49.60
+0.02
(+0.04%)
After-Hours: 20:00
Viking Therapeutics Shares Outstanding: 111.44M for Oct. 15, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 15, 2024 | 111.44M |
September 30, 2024 | 111.43M |
July 15, 2024 | 110.80M |
June 30, 2024 | 110.80M |
April 15, 2024 | 110.27M |
March 31, 2024 | 110.23M |
March 28, 2024 | 110.22M |
March 15, 2024 | 110.07M |
March 04, 2024 | 109.36M |
February 27, 2024 | 101.91M |
January 31, 2024 | 100.49M |
December 31, 2023 | 100.11M |
October 15, 2023 | 100.03M |
September 30, 2023 | 100.03M |
July 15, 2023 | 100.03M |
June 30, 2023 | 100.03M |
April 21, 2023 | 99.84M |
April 16, 2023 | 99.58M |
April 15, 2023 | 99.58M |
April 03, 2023 | 98.26M |
March 31, 2023 | 79.32M |
February 27, 2023 | 78.44M |
January 31, 2023 | 78.42M |
December 31, 2022 | 78.26M |
October 15, 2022 | 76.69M |
Date | Value |
---|---|
September 30, 2022 | 76.69M |
July 15, 2022 | 76.69M |
June 30, 2022 | 76.69M |
April 15, 2022 | 77.37M |
March 31, 2022 | 77.37M |
January 31, 2022 | 78.36M |
December 31, 2021 | 78.25M |
October 15, 2021 | 78.23M |
September 30, 2021 | 78.23M |
July 15, 2021 | 78.19M |
June 30, 2021 | 78.19M |
April 15, 2021 | 78.10M |
March 31, 2021 | 77.18M |
January 31, 2021 | 74.13M |
December 31, 2020 | 73.22M |
October 15, 2020 | 72.95M |
September 30, 2020 | 72.92M |
July 15, 2020 | 72.76M |
June 30, 2020 | 72.76M |
April 15, 2020 | 72.60M |
March 31, 2020 | 72.56M |
January 31, 2020 | 72.56M |
December 31, 2019 | 72.41M |
October 31, 2019 | 72.26M |
September 30, 2019 | 72.26M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
72.41M
Minimum
Dec 31 2019
111.44M
Maximum
Oct 15 2024
88.00M
Average
78.31M
Median
Shares Outstanding Benchmarks
Amgen Inc | 537.53M |
Eli Lilly and Co | 949.32M |
Pfizer Inc | 5.667B |
Structure Therapeutics Inc | 57.20M |
Altimmune Inc | 71.07M |